Pain Diary Use After Laparoscopic Cholecystectomy
PDP-LC
Randomized Controlled Trial on the Use of Pain Diary in Assessing Early Postoperative Pain Following Laparoscopic Cholecystectomy
2 other identifiers
interventional
142
1 country
1
Brief Summary
This randomized controlled study aims to evaluate the effectiveness of using a pain diary in the assessment of early postoperative pain in patients undergoing laparoscopic cholecystectomy. Patients will be randomly assigned to a pain diary group or a control group receiving routine pain assessment. Postoperative pain intensity will be measured at predefined time points using standardized pain assessment tools. The study seeks to improve patient participation in postoperative pain evaluation without introducing additional pharmacological interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2025
CompletedFirst Submitted
Initial submission to the registry
December 17, 2025
CompletedFirst Posted
Study publicly available on registry
December 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 30, 2027
January 6, 2026
December 1, 2025
9 months
December 17, 2025
December 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Pain Intensity and Pain Diary vs. VAS Comparison
The primary outcome measure involves postoperative pain intensity recorded by patients in the intervention group using a daily pain diary, compared to routine clinical VAS measurements in the control group. Measurements will be taken at 2, 4, 6, 12, 16, 20, 24, 32, and 48 hours post-surgery. Additionally, short pain inventories at 24 and 48 hours and VAS-based satisfaction evaluation before discharge will be performed.
During the first 48 hours post-surgery (measurements at 2, 4, 6, 12, 16, 20, 24, 32, and 48 hours postoperatively)
Secondary Outcomes (1)
Postoperative Pain Intensity
During the first 48 hours post-surgery (measurements at 2, 4, 6, 12, 16, 20, 24, 32, and 48 hours postoperatively)
Study Arms (2)
Pain Management Intervention Group
EXPERIMENTALParticipants in this group will follow the pain management protocol after laparoscopic cholecystectomy, including recording postoperative pain in a pain diary.
Control Group
NO INTERVENTIONParticipants in this group will receive standard care after laparoscopic cholecystectomy. Postoperative pain will be assessed using the Visual Analog Scale (VAS) at scheduled times by nurses and researchers, and recorded accordingly
Interventions
This pain management protocol is specifically tailored for patients undergoing laparoscopic cholecystectomy and combines both scheduled pharmacological analgesics and non-pharmacological pain control measures. Unlike other studies, it includes daily pain diary monitoring to objectively track patient-reported postoperative pain and recovery outcomes.
Eligibility Criteria
You may qualify if:
- Admitted for elective laparoscopic cholecystectomy
- Scheduled for first-time laparoscopic cholecystectomy
- Aged 18 years or older
- Able to speak, read, and understand Turkish
- Literate
- Communicative and cooperative
- ASA score of 1, 2, or 3
- Expected to stay at least 24 hours in the hospital post-surgery
- Capable of understanding study instructions
- Willing to participate voluntarily
You may not qualify if:
- Prolonged stay in the recovery unit due to extended effects of general anesthesia
- Admission to intensive care unit postoperatively
- Having chronic pain and receiving treatment for it
- Being a cancer patient
- Having a writing disability
- Inability to communicate
- Having cognitive, affective, verbal, visual, or auditory impairments
- Diagnosed psychiatric disorders such as anxiety or depression and using related medications
- Choosing to withdraw from the study after giving consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Menteşe State Hospital
Muğla, Menteşe, 48000, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Gülşah K KÖSE
Muğla Sıtkı Koçman University / Faculty of Health Sciences Department of Nursing
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking is performed in this study; both participants and researchers are aware of group assignments.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Graduate Student (MSc) in Surgical Nursing
Study Record Dates
First Submitted
December 17, 2025
First Posted
December 30, 2025
Study Start
November 15, 2025
Primary Completion (Estimated)
July 30, 2026
Study Completion (Estimated)
January 30, 2027
Last Updated
January 6, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Individual patient data and supporting information will be accessible from the date patients provide informed consent prior to surgery, throughout the data collection period, and for at least 5 years following study completion, stored in accordance with confidentiality principles
- Access Criteria
- Individual patient data and supporting information will be accessible only to the study research team. The research team will have access to patient names, surnames, socio-demographic information, medical history, and pain diary data via a secure, password-protected electronic database. The data will be used solely for study purposes and will not be shared with third parties
The specific individual patient data collected in this study include patient first and last names, signed informed consent forms, socio-demographic information (age, gender, etc.), medical history, and postoperative pain diary data. These data will be used solely for research purposes and shared in accordance with confidentiality principles